Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matias Viitala

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Brain and Behavior|February 12, 2025
Evolving Patterns of Initial RRMS Treatment in Finland (2013-2022): Insights From a Nationwide Multiple Sclerosis RegisterHenrik Ahvenjärvi, Elina Jokinen, Matias Viitala, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 19, 2026
Comorbidities in newly diagnosed multiple sclerosis patients: A population-based register study in FinlandHenrik Ahvenjärvi, Johanna Krüger, Matias Viitala, et al.
Acta Neurologica Scandinavica|July 5, 2019
Multiple sclerosis in Finland 2018-Data from the national registerSini M Laakso, Matias Viitala, Hanna Kuusisto, et al.
Multiple Sclerosis and Related Disorders|September 13, 2025
The real-world efficacy of Cladribine tablets and treatment persistence in people with highly active relapsing multiple sclerosis in Finland - A follow-up study after four years of observationIlkka Rauma, Matias Viitala, Merja Soilu-Hänninen, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 9, 2023
Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patientsAuli Verkkoniemi-Ahola, Päivi Hartikainen, Katja Hassi, et al.
JMIR Human Factors|August 22, 2025
Finnish Registry-Based Protocol for Screening and Management of Fatigue and Cognitive Problems in Multiple Sclerosis: Observational StudyPäivi Hämäläinen, Elina Lämsä, Matias Viitala, et al.
European Journal of Clinical Pharmacology|March 11, 2018
How do different extracorporeal circulation systems affect metoprolol bioavailability in coronary artery bypass surgery patientsHannu Kokki, Martin Maaroos, Sten Ellam, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 20, 2025
Evaluation of patient-perceived fatigue in multiple sclerosis utilizing the Finnish MS registryPäivi Hämäläinen, Matias Viitala, Merja Soilu-Hänninen, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 6, 2025
Delays in treatment initiation for patients with relapsing-remitting multiple sclerosis-A nationwide population-based studyMaiju Savolainen, Matias Viitala, Katariina Kuutti, et al.
Annals of Clinical and Translational Neurology|November 18, 2025
Network Localization of Fatigue in Multiple SclerosisOlli Likitalo, Jaakko Kungshamn, Albert Bellmunt-Gil, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Brain and Behavior|February 12, 2025
Evolving Patterns of Initial RRMS Treatment in Finland (2013-2022): Insights From a Nationwide Multiple Sclerosis RegisterHenrik Ahvenjärvi, Elina Jokinen, Matias Viitala, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 19, 2026
Comorbidities in newly diagnosed multiple sclerosis patients: A population-based register study in FinlandHenrik Ahvenjärvi, Johanna Krüger, Matias Viitala, et al.
Acta Neurologica Scandinavica|July 5, 2019
Multiple sclerosis in Finland 2018-Data from the national registerSini M Laakso, Matias Viitala, Hanna Kuusisto, et al.
Multiple Sclerosis and Related Disorders|September 13, 2025
The real-world efficacy of Cladribine tablets and treatment persistence in people with highly active relapsing multiple sclerosis in Finland - A follow-up study after four years of observationIlkka Rauma, Matias Viitala, Merja Soilu-Hänninen, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 9, 2023
Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patientsAuli Verkkoniemi-Ahola, Päivi Hartikainen, Katja Hassi, et al.
JMIR Human Factors|August 22, 2025
Finnish Registry-Based Protocol for Screening and Management of Fatigue and Cognitive Problems in Multiple Sclerosis: Observational StudyPäivi Hämäläinen, Elina Lämsä, Matias Viitala, et al.
European Journal of Clinical Pharmacology|March 11, 2018
How do different extracorporeal circulation systems affect metoprolol bioavailability in coronary artery bypass surgery patientsHannu Kokki, Martin Maaroos, Sten Ellam, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 20, 2025
Evaluation of patient-perceived fatigue in multiple sclerosis utilizing the Finnish MS registryPäivi Hämäläinen, Matias Viitala, Merja Soilu-Hänninen, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 6, 2025
Delays in treatment initiation for patients with relapsing-remitting multiple sclerosis-A nationwide population-based studyMaiju Savolainen, Matias Viitala, Katariina Kuutti, et al.
Annals of Clinical and Translational Neurology|November 18, 2025
Network Localization of Fatigue in Multiple SclerosisOlli Likitalo, Jaakko Kungshamn, Albert Bellmunt-Gil, et al.
Pageof 2